AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27

Authors: Yin, ZN Babaian, RJ Troncoso, P Strom, SS Spitz, MR Caudell, JJ Stein, JD Kagan, J
Citation: Zn. Yin et al., Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q, ONCOGENE, 20(18), 2001, pp. 2273-2280

Authors: Newman, RA Yang, J Finlay, MRV Cabral, F Vourloumis, D Stephens, LC Troncoso, P Wu, XB Logothetis, CJ Nicolaou, KC Navone, NM
Citation: Ra. Newman et al., Antitumor efficacy of 26-fluoroepothilone B against human prostate cancer xenografts, CANC CHEMOT, 48(4), 2001, pp. 319-326

Authors: Chang, S Hursting, SD Contois, JH Strom, SS Yamamura, Y Babaian, RJ Troncoso, P Scardino, PT Wheeler, TM Amos, CI Spitz, MR
Citation: S. Chang et al., Leptin and prostate cancer, PROSTATE, 46(1), 2001, pp. 62-67

Authors: Allsbrook, WC Mangold, KA Johnson, MH Lane, RB Lane, CG Amin, MB Bostwick, DG Humphrey, PA Jones, EC Reuter, VE Sakr, W Sesterhenn, IA Troncoso, P Wheeler, TM Epstein, JI
Citation: Wc. Allsbrook et al., Interobserver reproducibility of Gleason grading of prostatic carcinoma: Urologic pathologists, HUMAN PATH, 32(1), 2001, pp. 74-80

Authors: Troncoso, P Ortiz, M Martinez, L Kahan, BD
Citation: P. Troncoso et al., FTY 720 prevents ischemic reperfusion damage in ret kidneys, TRANSPLAN P, 33(1-2), 2001, pp. 857-859

Authors: Wistuba, II Tang, MY Maitra, A Alvarez, H Troncoso, P Pimental, F Gazdar, AF
Citation: Ii. Wistuba et al., Genome-wide allelotyping analysis reveals multiple sites of allelic loss in gallbladder carcinoma, CANCER RES, 61(9), 2001, pp. 3795-3800

Authors: Babaian, RJ Troncoso, P Bhadkamkar, VA Johnston, DA
Citation: Rj. Babaian et al., Analysis of clinicopathologic factors predicting outcome after radical prostatectomy, CANCER, 91(8), 2001, pp. 1414-1422

Authors: Kuniyasu, H Troncoso, P Johnston, D Bucana, CD Tahara, E Fidler, IJ Pettaway, CA
Citation: H. Kuniyasu et al., Relative expression of type IV collagenase, E-cadherin, and vascular endothelial growth factor/vascular permeability factor in prostatectomy specimens distinguishes organ-confined from pathologically advanced prostate cancers, CLIN CANC R, 6(6), 2000, pp. 2295-2308

Authors: Navone, NM Rodriguez-Vargas, MD Benedict, WF Troncoso, P McDonnell, TJ Zhou, JH Luthra, R Logothetis, CJ
Citation: Nm. Navone et al., TabBO: A model reflecting common molecular features of androgen-independent prostate cancer, CLIN CANC R, 6(3), 2000, pp. 1190-1197

Authors: Pettaway, CA Pisters, LL Troncoso, P Slaton, J Finn, L Kamoi, K Logothetis, CJ
Citation: Ca. Pettaway et al., Neoadjuvant chemotherapy and hormonal therapy followed by radical prostatectomy: Feasibility and preliminary results, J CL ONCOL, 18(5), 2000, pp. 1050-1057

Authors: Kamoi, K Troncoso, P Babaian, RJ
Citation: K. Kamoi et al., Strategy for repeat biopsy in patients with high grade prostatic intraepithelial neoplasia, J UROL, 163(3), 2000, pp. 819-823

Authors: Babaian, RJ Toi, A Kamoi, K Troncoso, P Sweet, J Evans, R Johnston, D Chen, M
Citation: Rj. Babaian et al., A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy, J UROL, 163(1), 2000, pp. 152-157

Authors: Spitz, MR Strom, SS Yamamura, Y Troncoso, P Babaian, RJ Scardino, PT Wheeler, T Amos, CI von Eschenbach, A
Citation: Mr. Spitz et al., Epidemiologic determinants of clinically relevant prostate cancer, INT J CANC, 89(3), 2000, pp. 259-264

Authors: Chen, ME Johnston, DA Tang, K Babaian, RJ Troncoso, P
Citation: Me. Chen et al., Detailed mapping of prostate carcinoma foci - Biopsy strategy implications, CANCER, 89(8), 2000, pp. 1800-1809

Authors: Fidler, IJ Kuniyasu, H Greene, GF Troncoso, P Pettaway, CA
Citation: Ij. Fidler et al., Molecular diagnosis to predict the metastatic potential of human prostate cancer, PROG ANTI C, 4, 2000, pp. 153-161

Authors: Pisters, LL Pettaway, CA Hossan, E Evans, R Steiner, MS Wood, CG Troncoso, P McDonnell, TJ Fenstenmacher, MJ Logothetis, CJ
Citation: Ll. Pisters et al., Intraprostatic AD-p53 gene therapy followed by radical prostatectomy: feasibility and preliminary results, PROSTATE C, 2, 1999, pp. S27-S27

Authors: Sans, J Aguilera, AM Faundez, P Troncoso, P Fernandez, V Videla, LA
Citation: J. Sans et al., Influence of copper-(II) on colloidal carbon-induced Kupffer cell-dependent oxygen uptake in rat liver: Relation to hepatotoxicity, FREE RAD RE, 30(6), 1999, pp. 489-498

Authors: Yin, ZN Spitz, MR Babaian, RJ Strom, SS Troncoso, P Kagan, J
Citation: Zn. Yin et al., Limiting the location of a putative human prostate cancer tumor suppressorgene at chromosome 13q14.3, ONCOGENE, 18(52), 1999, pp. 7576-7583

Authors: Ellerhorst, J Troncoso, P Xu, XC Lee, J Lotan, R
Citation: J. Ellerhorst et al., Galectin-1 and galectin-3 expression in human prostate tissue and prostatecancer, UROL RES, 27(5), 1999, pp. 362-367

Authors: Khoo, VS Pollack, A Cowen, D Joon, DL Patel, N Terry, NHA Zagars, GK von Eschenbach, AC Meistrich, ML Troncoso, P
Citation: Vs. Khoo et al., Relationship of Ki-67 labeling index to DNA-ploidy, S-phase fraction, and outcome in prostate cancer treated with radiotherapy, PROSTATE, 41(3), 1999, pp. 166-172

Authors: Chen, ME Troncoso, P Tang, K Babaian, RJ Johnston, D
Citation: Me. Chen et al., Comparison of prostate biopsy schemes by computer simulation, UROLOGY, 53(5), 1999, pp. 951-960

Authors: Chen, ME Troncoso, P Johnston, D Tang, K Babaian, RJ
Citation: Me. Chen et al., Prostate cancer detection: Relationship to prostate size, UROLOGY, 53(4), 1999, pp. 764-768

Authors: Troncoso, P Stepkowski, SM Wang, ME Qu, XM Chueh, SC Clark, J Kahan, BD
Citation: P. Troncoso et al., Prophylaxis of acute renal allograft rejection using FTY720 in combinationwith subtherapeutic doses of cyclosporine, TRANSPLANT, 67(1), 1999, pp. 145-151

Authors: Pisters, LL Dinney, CPN Pettaway, CA Scott, SM Babaian, RJ von Eschenbach, AC Troncoso, P
Citation: Ll. Pisters et al., A feasibility study of cryotherapy followed by radical prostatectomy for locally advanced prostate cancer, J UROL, 161(2), 1999, pp. 509-514

Authors: Navone, NM Labate, ME Troncoso, P Pisters, LL Conti, CJ Von Eschenbach, AC Logothetis, CJ
Citation: Nm. Navone et al., p53 mutations in prostate cancer bone metastases suggest that selected p53mutants in the primary site define foci with metastatic potential, J UROL, 161(1), 1999, pp. 304-308
Risultati: 1-25 | 26-27